Bone Changes During Growth in Patients with Osteogenesis Imperfecta

被引:0
|
作者
Burgueno-Torres, Laura [1 ]
Garcia-Boedo, Lara [1 ]
de Nova-Garcia, Manuel Joaquin [1 ]
机构
[1] Univ Complutense Madrid, Fac Dent, Dent Clin Specialties Dept, Madrid 28040, Spain
关键词
osteogenesis imperfecta; biphosphonates; orthopantomography; panoramic index; pediatric patient; PANORAMIC MANDIBULAR INDEXES; RADIOMORPHOMETRIC INDEXES; FRACTAL DIMENSION; CHILDREN; PAMIDRONATE; THERAPY; DENSITY; DIAGNOSIS; GENDER; CORTEX;
D O I
10.3390/jcm14051764
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Objectives: Osteogenesis Imperfecta (OI) is a congenital disorder, in which the production of collagen, mainly type I, is altered, leading to a decrease in bone mineral density, increasing the risk of fracture with minimal trauma. Several studies have analyzed bone mineral density in osteoporotic patients based on linear measurements such as radiomorphometric indices measured with panoramic radiographs, although few studies have investigated bone trabeculation in children diagnosed with OI. Therefore, the aim of the present investigation was to analyze the dental panoramic indices in panoramic radiographs in the cortical and trabeculated bone of children with OI. Methods: Thus, 66 pediatric patients diagnosed with OI under antiresorptive treatment were compared with a sample of controls matched for sex and age. Using Image J software (version: 1.54d), three radiomorphometric indices were analyzed in orthopantomographies of the study and control groups, evaluating the influence of disease severity as well as the type of antiresorptive treatment administered. Results: Patients with OI had a higher presence of type C2 and C3 MCI (mandibular cortical index) than their matched controls (p < 0.05), although no differences were found for the visual estimation of cortical width (SVE) and mandibular cortical width (MCW). Treatment with zoledronic acid was associated with a higher number of cases of type C1 MCI, in terms of sample description, while patients treated with a combination of pamidronate and zoledronic acid had a higher rate of type C1 and C2 MCI, with no statistical differences. Conclusions: In the overall sample, most patients showed a thin SVE index (59.1%), a C2 or C1 type MCI (46.2% and 42.4%) and an MCW of 2.9 mm. Differences in bone mineral density were also observed throughout growth and the different antiresorptive treatments. Zoledronic acid has been associated with a higher percentage of C1 and C3 ICM, and pamidronate alone or in combination is associated with a C1 and C2 MCI index.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Scoliosis in osteogenesis imperfecta: results of posterior spinal fusion in 39 patients
    Rabau, Oded
    Essa, Ahmad
    Smorgick, Yossi
    Anekstein, Yoram
    Abhishek, Kumar
    Saran, Neil
    Ouellet, Jean
    EUROPEAN SPINE JOURNAL, 2023, 32 (04) : 1146 - 1152
  • [22] Analysis of Craniocervical Abnormalities in Osteogenesis Imperfecta during Growth
    De Nova-Garcia, Manuel Joaquin
    Sola, Rafael G.
    Burgueno-Torres, Laura
    APPLIED SCIENCES-BASEL, 2024, 14 (04):
  • [23] Advances in the Classification and Treatment of Osteogenesis Imperfecta
    Thomas, Inas H.
    DiMeglio, Linda A.
    CURRENT OSTEOPOROSIS REPORTS, 2016, 14 (01) : 1 - 9
  • [24] Pathophysiology and therapeutic options in osteogenesis imperfecta
    Semler, Oliver
    Kornak, Uwe
    Oheim, Ralf
    Seefried, Lothar
    OSTEOLOGIE, 2020, 29 (04) : 302 - 310
  • [25] Bone mass and mineralization in osteogenesis imperfecta; [Knochenmasse und Mineralgehalt in Osteogenesis imperfecta]
    Fratzl-Zelman N.
    Misof B.M.
    Klaushofer K.
    Roschger P.
    Wiener Medizinische Wochenschrift, 2015, 165 (13-14) : 271 - 277
  • [26] Genotype and phenotype analysis of Taiwanese patients with osteogenesis imperfecta
    Lin, Hsiang-Yu
    Chuang, Chih-Kuang
    Su, Yi-Ning
    Chen, Ming-Ren
    Chiu, Hui-Chin
    Niu, Dau-Ming
    Lin, Shuan-Pei
    ORPHANET JOURNAL OF RARE DISEASES, 2015, 10
  • [27] Role of an interdisciplinary approach in the healing of long bone fractures in patients with osteogenesis imperfecta
    Kokavec, M.
    Novorolsky, K.
    Pribiuncova, Z.
    ACTA CHIRURGIAE ORTHOPAEDICAE ET TRAUMATOLOGIAE CECHOSLOVACA, 2008, 75 (03) : 185 - 189
  • [28] OSTEOGENESIS IMPERFECTA - COMPARISON OF MOLECULAR DEFECTS WITH BONE HISTOLOGICAL-CHANGES
    SZTROLOVICS, R
    GLORIEUX, FH
    TRAVERS, R
    VANDERREST, M
    ROUGHLEY, PJ
    BONE, 1994, 15 (03) : 321 - 328
  • [29] The functional muscle-bone unit in patients with osteogenesis imperfecta type I
    Veilleux, Louis-Nicolas
    Pouliot-Laforte, Annie
    Lemay, Martin
    Cheung, Moira S.
    Glorieux, Francis H.
    Rauch, Frank
    BONE, 2015, 79 : 52 - 57
  • [30] Pathophysiology and Therapy for Patients with Osteogenesis imperfecta
    Semler, O.
    Rehberg, M.
    Hoyer-Kuhn, H.
    OSTEOLOGIE, 2018, 27 (04) : 194 - 199